HSE spent €1.2bn on biologic medicines

More than €1.2bn has been spent by the HSE in reimbursing biologic medicines over the last three years with just over €2.2m spent on more affordable biosimilar medicines, it has emerged.

HSE spent €1.2bn on biologic medicines

More than €1.2bn has been spent by the HSE in reimbursing biologic medicines over the last three years with just over €2.2m spent on more affordable biosimilar medicines, it has emerged.

The health authority is spending almost €450m annually on biologics and just over €1m on more affordable biosimilar medicines.

Already a subscriber? Sign in

You have reached your article limit.

Unlimited access. Half the price.

Annual €120 €60

Best value

Monthly €10€5 / month

More in this section

Lunchtime News

Newsletter

Keep up with stories of the day with our lunchtime news wrap and important breaking news alerts.

Cookie Policy Privacy Policy Brand Safety FAQ Help Contact Us Terms and Conditions

© Examiner Echo Group Limited